ETON: Eton Pharmaceuticals, Inc.
About
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.
Current Value
$10.501 Year Return
Current Value
$10.501 Year Return
Key Details
Market Cap
$271.28M
P/E Ratio
-49.18
1Y Stock Return
195.77%
1Y Revenue Growth
5.64%
Dividend Yield
0.00%
Price to Book
17.0
Strategies that include ETON
Stock's related to ETON
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| GDOT | 36.12% | $573.37M | +28.74% | 0.00% |
| SSYS | 35.46% | $647.34M | -15.06% | 0.00% |
| MRSN | 28.33% | $274.24M | +40.51% | 0.00% |
| SOLV | 28.30% | $11.58B | -16.19% | 0.00% |
| EVGO | 27.32% | $625.86M | +97.63% | 0.00% |
| GPMT | 27.12% | $173.85M | -33.97% | 13.01% |
| EXPI | 26.60% | $1.97B | +3.63% | 1.56% |
| TROW | 26.59% | $26.20B | +21.60% | 4.19% |
| WWW | 26.57% | $1.79B | +171.57% | 1.80% |
| FAF | 26.52% | $6.82B | +15.96% | 3.22% |
| EGP | 26.52% | $8.62B | +2.17% | 3.00% |
| FFBC | 26.50% | $2.75B | +42.24% | 3.23% |
| OGN | 26.37% | $3.76B | +32.28% | 7.69% |
| TMHC | 26.35% | $7.19B | +55.90% | 0.00% |
| FULT | 26.32% | $3.77B | +47.51% | 3.27% |
| OVID | 26.27% | $73.14M | -68.60% | 0.00% |
| TRNO | 26.25% | $6.04B | +9.22% | 3.06% |
| ADMA | 26.24% | $4.88B | +423.60% | 0.00% |
| BANF | 26.23% | $4.02B | +41.10% | 1.44% |
| ACRE | 26.18% | $388.89M | -28.20% | 15.31% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NFLX | 0.04% | $372.45B | +83.46% | 0.00% |
| DESP | -0.05% | $1.16B | +111.97% | 0.00% |
| TNK | -0.05% | $1.48B | -12.01% | 2.31% |
| OLLI | -0.08% | $5.48B | +15.97% | 0.00% |
| AG | 0.08% | $2.01B | +21.76% | 0.28% |
| ORKA | -0.09% | $780.47M | +82.82% | 0.00% |
| BVS | 0.13% | $757.61M | +201.04% | 0.00% |
| PBT | 0.14% | $606.38M | -27.11% | 5.87% |
| PDD | 0.16% | $163.43B | +0.29% | 0.00% |
| MOD | 0.17% | $7.14B | +163.53% | 0.00% |
| BYD | 0.17% | $6.32B | +21.62% | 0.94% |
| KRP | 0.17% | $1.29B | +2.58% | 11.03% |
| SBUX | -0.18% | $111.45B | -5.15% | 2.37% |
| COGT | -0.21% | $1.00B | +31.69% | 0.00% |
| ALAB | 0.22% | $15.10B | +164.39% | 0.00% |
| DLTH | -0.23% | $124.02M | -31.26% | 0.00% |
| AB | -0.24% | $4.14B | +29.43% | 8.13% |
| BTU | 0.25% | $3.23B | +14.05% | 1.13% |
| TRGP | -0.25% | $44.39B | +132.49% | 1.34% |
| PBYI | -0.27% | $134.50M | -28.83% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MNOV | -17.22% | $93.19M | +2.15% | 0.00% |
| APRE | -15.97% | $16.41M | -19.47% | 0.00% |
| GERN | -15.78% | $2.29B | +97.40% | 0.00% |
| IX | -13.74% | $24.86B | +20.18% | 1.69% |
| CRVO | -13.43% | $83.20M | +2.86% | 0.00% |
| NHTC | -12.15% | $61.83M | +0.19% | 14.81% |
| TCTM | -11.80% | $8.10M | -42.99% | 0.00% |
| OXBR | -11.09% | $19.05M | +178.18% | 0.00% |
| VZIO | -10.89% | $2.29B | +67.76% | 0.00% |
| EFR | -9.36% | $1.42B | -14.34% | 0.00% |
| SPR | -9.30% | $3.72B | +23.27% | 0.00% |
| WRAP | -8.80% | $62.86M | -49.45% | 0.00% |
| FF | -8.56% | $227.57M | +21.57% | 4.55% |
| BSX | -8.17% | $133.13B | +63.29% | 0.00% |
| QD | -7.97% | $335.92M | +42.44% | 0.00% |
| TKC | -7.85% | $5.80B | +35.51% | 1.30% |
| NOMD | -7.81% | $2.74B | +4.53% | 2.67% |
| TAL | -7.75% | $4.54B | +2.16% | 0.00% |
| YY | -7.60% | $1.47B | -12.63% | 0.00% |
| TCOM | -7.57% | $40.41B | +91.40% | 0.00% |
ETF's related to ETON
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| PBE | 32.17% | $258.53M | 0.58% |
| FBT | 32.12% | $1.11B | 0.56% |
| GNOM | 29.42% | $70.59M | 0.5% |
| IBB | 29.40% | $6.66B | 0.45% |
| XPH | 29.19% | $157.87M | 0.35% |
| XBI | 29.08% | $6.58B | 0.35% |
| PRNT | 28.17% | $95.35M | 0.66% |
| BBH | 28.04% | $397.87M | 0.35% |
| WCLD | 27.84% | $454.67M | 0.45% |
| SMMV | 27.61% | $321.07M | 0.2% |
| CORP | 27.58% | $1.25B | 0.23% |
| IWC | 27.50% | $933.99M | 0.6% |
| CLOU | 27.49% | $349.39M | 0.68% |
| ARKG | 27.42% | $1.13B | 0.75% |
| RSPH | 27.32% | $885.96M | 0.4% |
| FXH | 27.29% | $1.15B | 0.62% |
| VIOO | 27.20% | $3.12B | 0.1% |
| PTH | 27.11% | $143.31M | 0.6% |
| IXJ | 27.08% | $3.89B | 0.41% |
| IHE | 26.99% | $596.23M | 0.39% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| FLTR | 0.04% | $1.79B | 0.14% |
| KLIP | -0.07% | $125.85M | 0.93% |
| PHDG | 0.10% | $113.97M | 0.39% |
| BCD | 0.10% | $245.02M | 0.3% |
| CANE | -0.17% | $17.72M | 0.29% |
| FMF | 0.29% | $244.61M | 0.95% |
| IBHD | -0.32% | $327.80M | 0.35% |
| BCI | -0.40% | $1.20B | 0.26% |
| IVOL | 0.42% | $548.70M | 1.02% |
| CSHI | 0.56% | $482.85M | 0.38% |
| URA | -0.57% | $3.55B | 0.69% |
| FLOT | 0.63% | $7.31B | 0.15% |
| FTGC | -0.81% | $2.17B | 1.02% |
| HIGH | 1.00% | $302.78M | 0.51% |
| XBIL | 1.02% | $637.70M | 0.15% |
| CCOR | 1.16% | $109.04M | 1.18% |
| CMDY | 1.18% | $279.14M | 0.28% |
| DXJ | 1.32% | $3.71B | 0.48% |
| WEAT | -1.37% | $120.27M | 0.28% |
| USCI | -1.43% | $185.47M | 1.07% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -24.53% | $388.04M | 1.43% |
| TBIL | -16.94% | $4.38B | 0.15% |
| EQLS | -14.00% | $76.08M | 1% |
| CTA | -13.34% | $350.27M | 0.78% |
| MSOS | -12.06% | $632.80M | 0.83% |
| IBTE | -11.86% | $1.70B | 0.07% |
| BOXX | -11.35% | $4.43B | 0.1949% |
| VIXY | -11.13% | $195.31M | 0.85% |
| IBDP | -9.87% | $2.11B | 0.1% |
| CNBS | -9.60% | $21.10M | 0.77% |
| YOLO | -8.81% | $34.71M | 1.03% |
| COMT | -8.28% | $829.06M | 0.48% |
| FLRN | -8.08% | $2.33B | 0.15% |
| CPER | -7.80% | $159.52M | 0.97% |
| KMLM | -7.71% | $353.87M | 0.9% |
| URNJ | -7.62% | $283.55M | 0.8% |
| URNM | -7.41% | $1.61B | 0.75% |
| DBA | -7.41% | $755.88M | 0.93% |
| AGZD | -6.79% | $142.76M | 0.23% |
| DBO | -6.72% | $217.57M | 0.77% |
News
Yahoo
Eton Pharmaceuticals ( NASDAQ:ETON ) Third Quarter 2024 Results Key Financial Results Revenue: US$10.3m (up 47% from 3Q...
Yahoo
Q3 2024 Eton Pharmaceuticals Inc Earnings Call
Yahoo
Eton Pharmaceuticals Inc (ETON) reports a milestone quarter with significant sales growth, strategic acquisitions, and promising pipeline advancements.
Yahoo
Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million, or $0.02 per diluted shareEntered into an asset purchase agreement to acquire Increlex® (mecasermin injection)Q3 2024 product sales increased 40% over Q3 2023, representing 15th straight quarter of sequential product sales growthProduced positive quarterly GAAP net income from product sales for first time in company historyGenerated cash from operations of $2.9 million in Q3 2024Granted additional patent for ET-400Manag
SeekingAlpha
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ETCompany ParticipantsDavid Krempa â Chief Business...
Finnhub
DEER PARK - Eton Pharmaceuticals, Inc , an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that the United States Patent and...
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.